Pamela P Palmer
CIK 1511365 · Chief Medical Officer · last filed 2024-03-04
Pamela P Palmer is a Chief Medical Officer who has filed 35 SEC Form 4 insider transactions across 2 companies since 2011. The most recent filing shows the insider had shares withheld for taxes covering $585 of TLPH on Mar 4, 2024. Across all open-market trades the lifetime net is +$204.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $76.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$76.9K
2
35
$204.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TLPH | Chief Medical Officer | 59,149 | $1.30 | $76.9K | $0 | 3 | 2024-03-04 |
| TALPHERA, INC. (ACRX) Delisted | Chief Medical Officer | 38,195 | $0.86 | $32.8K | $204.0K | 30 | 2023-08-25 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-03-04 | TLPH | Tax (F) | −450 | -$585 | EDGAR |
| 2024-02-27 | TLPH | Grant (A) | +18,000 | $0 | EDGAR |
| 2024-02-13 | TLPH | Tax (F) | −1,602 | -$1.8K | EDGAR |
| 2023-08-25 | TLPH | Notice (144) | −7,450 | -$8.2K | EDGAR |
| 2023-08-25 | TALPHERA, INC. (ACRX) Delisted | Sell (S) | −16,956 | -$19.2K | EDGAR |
| 2023-08-24 | TLPH | Notice (144) | −9,514 | -$11.2K | EDGAR |
| 2023-03-06 | TALPHERA, INC. (ACRX) Delisted | Tax (F) | −570 | -$747 | EDGAR |
| 2023-02-14 | TALPHERA, INC. (ACRX) Delisted | Mixed | +5,108 | -$1.7K | EDGAR |
| 2023-02-08 | TALPHERA, INC. (ACRX) Delisted | Tax (F) | −681 | -$1.4K | EDGAR |
| 2022-03-04 | TALPHERA, INC. (ACRX) Delisted | Tax (F) | −7,923 | -$3.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.